How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,928 results for

Nutrition

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

122. Prevention, Diagnosis and Management of Colorectal Anastomotic Leakage

. There is experimental evidence of increased risk of AL for several immunosuppressant drugs used in patients who have undergone organ transplantation. This is consistent with reports of a higher AL rate in immunosuppressed patients after renal transplantation 20 .10 Table 1. Medication associated with increased risk of AL. Nutrition and Hypoalbuminaemia Malnutrition (defined as an unintentional loss of weight of >10% in the preceding 6 months), and a serum albumin concentration of 10% unintentional weight loss (...) of these factors are interrelated. For example, late presentation with advanced disease is likely to be associated not only with lower socioeconomic status, but also poor nutritional status, smoking and medical comorbidity. Intraoperative considerations Operative Technique Poor operative technique, for example, failing to avoid tension on, or poor vascularity at an anastomosis will impact negatively on anastomotic healing and is likely to result in AL. Operative duration of greater than 4 hours, intraoperative

2016 Association of Coloproctology of Great Britain and Ireland

123. Assessment, diagnosis and interventions for autism spectrum disorders

for children and young people 21 6.1 Parent-mediated interventions 21 6.2 Communication interventions 21 6.3 Behavioural/psychological interventions 23 6.4 Nutritional interventions 28 6.5 Other interventions 28 7 Non-pharmacological interventions for adults 29 7.1 Communication interventions 29 7.2 Facilitated communication 29 7.3 Social skills interventions 29 7.4 Behavioural interventions 30 7.5 Cognitive behavioural therapies 30 8 Pharmacological interventions for children and young people 32 8.1 (...) behavioural challenges Updated 6.4 Nutritional interventions Updated 6.5 Other interventions New 7 Non-pharmacological interventions for adults New 8 Pharmacological interventions for children and young people 8.2 Second-generation antipsychotics Completely revised 8.3 Methylphenidate Updated 8.4 Noradrenergic reuptake inhibitors New 8.5 Antidepressants New 8.6 Naltrexone No new evidence identified 8.7.1 Secretin Updated 8.7.2 Oxytocin New 8.8 Melatonin Completely revised| 3 Assessment, diagnosis

2016 SIGN

125. Recommendations on screening for developmental delay

Jaramillo Garcia MSc, Wendy Martin PhD, Sarah Connor Gorber PhD, Anne-Marie Ugnat PhD, Marianna Ofner, PhD RN, Brett D. Thombs PhD Affiliations: Department of Medicine (Tonelli), University of Calgary, Calgary, Alta.; Department of Pediatrics (Parkin), Faculty of Medicine, University of Toronto, Toronto, Ont.; Department of Pediatrics (Leduc), Faculty of Medicine, McGill University Health Centre, Montréal, Que.; Depart- ment of Family Relations and Applied Nutrition (Brauer), University of Guelph

2016 CPG Infobase

126. Use of multiple micronutrient powders for point-of-use fortification of foods consumed by pregnant women

micronutrient powders for point-of-use fortification of foods consumed by pregnant women 17 ANNEX 3. WHO Steering Committee for Nutrition Guidelines Development 18 ANNEX 4. WHO guideline development group – nutrition actions 2013–2014 20 ANNEX 5. WHO Secretariat 22 ANNEX 6. External resource experts 23 ANNEX 7. Peer-reviewers 24 ANNEX 8. Questions in population, intervention, control, outcomes (PICO) format 25WHO Guideline: Use of multiple micronutrient powders for point-of-use fortification of foods (...) , Ministry of Health, Mexico, for their support in the preparation of one of the consultative meetings where this guideline was discussed. WHO acknowledges the technical contribution from the following individuals (in alphabetical order): Ms Mónica Flores-Urrutia, Dr Jonathan Siekmann and Dr Pattanee Winichagoon. Ms Jennifer Volonnino from the Evidence and Programme Guidance Unit, Department of Nutrition for Health and Development, provided logistic support. WHO gratefully acknowledges the technical

2016 World Health Organisation Guidelines

127. Daily iron supplementation in infants and children

for determining the strength of the recommendation for daily iron supplementation in malaria-endemic areas 34 ANNEX 6. WHO Steering Committee for Nutrition Guidelines Development 35 ANNEX 7. WHO guideline development group 36 ANNEX 8. External resource experts 39 ANNEX 9. WHO Secretariat 40 ANNEX 10. Peer-reviewers 41 ANNEX 11. Questions in population, intervention, control, outcomes (PICO) format 42 A. Effects and safety of daily iron supplementation in infants and young children aged 6–23 months 42 B (...) . Effects and safety of daily iron supplementation in children aged 24–59 months 43 C. Effects and safety of daily iron supplementation in children aged 60 months and older 44WHO Guideline: Daily iron supplementation in infants and children. vii ACKNOWLEDGEMENTS This guideline was coordinated by the World Health Organization (WHO) Evidence and Programme Guidance Unit, Department of Nutrition for Health and Development. Dr Pura Rayco-Solon, Dr Lisa Rogers and Dr Juan Pablo Peña-Rosas oversaw

2016 World Health Organisation Guidelines

128. Daily iron supplementation in adult women and adolescent girls

REFERENCES 14 ANNEX 1. GRADE summary of findings table 16 ANNEX 2. Summary of the considerations of the members of the guideline development group for determining the strength of the recommendation for daily oral iron supplementation in menstruating adult women and adolescent girls 17 ANNEX 3. WHO Steering Committee for Nutrition Guidelines Development 18 ANNEX 4. WHO guideline development group 19 ANNEX 5. External resource experts 22 ANNEX 6. WHO SECRETARIAT 23 ANNEX 7. PEER-REVIEWERS 24 ANNEX 8 (...) . Questions in population, intervention, control, outcomes (PICO) format 25 Effects and safety of iron supplementation in menstruating adult women and adolescent girls 25WHO Guideline: Daily iron supplementation in adult women and adolescent girls vi ACKNOWLEDGEMENTS This guideline was coordinated by the World Health Organization (WHO) Evidence and Programme Guidance Unit, Department of Nutrition for Health and Development. Dr Pura Rayco-Solon, Dr Lisa Rogers and Dr Juan Pablo Peña-Rosas oversaw

2016 World Health Organisation Guidelines

129. Guidelines for blood pressure measurement, diagnosis, and assessment of risk of pediatric hypertension

surrogate markers and consider the future implications of BP values documented during childhood. Table2. DeterminingnormativedataforBPvaluesinchildren(GradeD) 1. The BP tables use growth parametersas de?ned by the Centers for Disease Control and Prevention (CDC) growth charts. 2. The normative BP data obtained with auscultatory method includes the US National Health and Nutrition Examination Survey from 1999-2000. Normative BP data for oscillometric measurements are now available. 3. To determine BP (...) NationalSurveyenvironment.JClinHypertens (Greenwich) 2010;12:22-8. 18. Ostchega Y, Zhang G, Sorlie P, et al. Blood pressure randomized methodology study comparing automatic oscillometric and mercury sphygmomanometer devices: National Health and Nutrition Examina- tion Survey, 2009-2010. Natl Health Stat Report 2012;59:1-15. 19. Foster TA, Berenson GS. Measurement error and reliability in four pediatric cross-sectional surveys of cardiovascular disease risk factor variablesdThe Bogalusa Heart Study. J Chronic Dis 1987;40:13-21. 20

2016 CPG Infobase

130. Esophageal cancer

• Complete a work-up (as described above) and review the patient’s case with the multidisciplinary team. Early referral to a surgeon trained in esophageal surgery is important to assess for resectability. • Assess the degree of dysphagia and consult with a dietician to optimize the patient’s nutritional status. Consider placement of a nasogastic (NG) feeding tube. If the NG feeding tube insertion is technically difficult, placement should be performed radiographically. In a curative situation, avoid

2016 CPG Infobase

132. Safe vascular access

). Elective care 5 Hospitals must organise and provide the follow- ing: Timely (within 1–3 days) insertion (and removal) of long-term CVCs in specialised loca- tions (wards, theatres, radiology) via a dedi- cated service. This has been highlighted in the context of total parenteral nutrition administra- tion [4]. All acute hospitals will have requirements for long-term or repeated short-term central venous access, both in the NHS and independent sector. There are varied models dependent on local workload (...) . An enquiry into the care of hospital patients receiving parenteral nutrition. http://www.nce- pod.org.uk/2010report1/downloads/PN_report.pdf (accessed 24/08/2015). 5. Standards for infusion therapy. The Royal College of Nurses, 2010. http://www.bbraun.it/documents/RCN-Guidlines-for-IV- therapy.pdf (accessed 24/08/2015). 6. http://www.nrls.npsa.nhs.uk/patient-safety-data/organisation- patient-safety-incident-reports/ (accessed 17/10/2015). 7. Hove LD, Steinmetz J, Christoffersen JK, et al. Analysis

2016 Association of Anaesthetists of GB and Ireland

133. Legal and Ethical Issues related to Resuscitation

or withdraw a life-sustaining measure (including artificial nutrition and hydration) operates only while the victim has impaired capacity and cannot operate unless the victim has no reasonable prospect of regaining capacity and has: (1) a terminal illness from which death is reasonably expected within 1 year, or (2) is in a persistent vegetative state, or (3) is permanently unconscious (in coma), or (4) has an illness or injury of such severity that there is no reasonable prospect of recovery without (...) to Medical Treatment and Palliative Care Act 1995, July 2014) A medical practitioner or a person under their supervision is under no duty to use, or continue to use, life sustaining measures (including CPR, assisted ventilation, artificial nutrition and hydration) in treating a victim if the effect of doing so would be merely to prolong life in (either) a moribund state without any real prospect of recovery or in a persistent vegetative state (whether or not the victim or the victim’s representative has

2015 Australian Resuscitation Council

134. After the Resuscitation of a Newborn Infant

be provided. 3,4 An infant who has experienced perinatal compromise or has ongoing respiratory distress may have dysfunction or delayed perinatal adaptation of brain, heart, gastrointestinal tract, kidneys or other organs. Fluid balance and nutrition should be monitored carefully for the first few days. 2.1 Cardiorespiratory management Usually, any infant who has been intubated and ventilated for resuscitation should not be extubated until the infant has been carefully assessed and the risk of the need

2016 Australian Resuscitation Council

136. Height: measuring a child/young person

Height: measuring a child/young person Height: measuring a child/young person | Great Ormond Street Hospital Google Tag Manager Navigation Search Search You are here Height: measuring a child/young person Height: measuring a child/young person . It provides a sensitive guide to a child/young person’s: health development nutritional status response to treatment A healthy adequately nourished and emotionally secure child/young person grows at an optimal rate . Regular measurements of children (...) records plotted accurately on the electronic growth charts on EDM The technique used to obtain an accurate measurement of height or length is crucial . Measurements must be recorded in centimetres and documented in the following areas: recorded in the child/young person’s health care/parent held record recorded in the Patient Assessment Form (PAF) / Outpatient Assessment form (OSF) recorded on the Nutrition Screening Flowchart recorded on the patients electronic records including electronic

2014 Publication 1593

137. Extravasation and infiltration

Calcium gluconate 10% Potassium chloride 7.45% Sodium bicarbonate 4.2% & 8.4% Sodium chloride 10% Cytotoxic agents Busulphan Actinomycin-D Daunorubicin Doxorubicin Epirubicin Idarubicin Mitomycin Paclitaxel Treosulfan Vinblastine Vincristine Vinorelbine Hyperosmolar agents Total parenteral nutrition >10% dextrose Mannitol 15% Other Radiographic contrast media Promethazine (phenergan) Diazepam Digoxin ( ) This is not an exhaustive list. Risk factors for infiltration and extravasation Risk factors (...) for vesicant administration pH of drug/fluid (extremes of pH ie acid or alkaline - pH < 5 or >9) osmolarity of drug/fluid (osmolarity >375 can influence the degree of tissue damage eg hypertonic drugs/solutions eg 10% Dextrose and parenteral nutrition solutions) vasoconstrictive potential (extravasation of vasoconstrictive substances eg dobutamine, dopamine, epinephrine, norepinephrine and vasopressin can cause ischaemic necrosis) cytotoxicity (drugs that bind to DNA can cause greater damage and may remain

2014 Publication 1593

138. Glomerular filtration rate measurement: Iohexol(TM) method

to patients receiving maintenance fluids (appropriate for body weight), total parenteral nutrition (TPN) or electrolyte supplements. GFR testing may take place in these patients. The child’s temperature must be recorded prior to commencement of the test. The test should be rescheduled in the event of pyrexia (>38°C) ( ). Confirm with the appropriate team prior to cancelling the test. Patients due to receive radioiodine therapy in the next week ( ). Patients who have eaten a heavy meal including large

2014 Publication 1593

139. Gastrostomy management

(1995) Paralytic ileus and enteral feeding. British Journal of Intensive Care 5(4): 117-8 Reference 2 Braegger I, Desci T, Dias JA, Hartman C, Kolacěk S, Koletzko B, Koletzko S, Mihatsch W, Moreno L, Punits J, Shamir R, Szajewska H, Turck D, Van Goudoever J (2010) Journal of Paediatric Gastroenterology and Nutrition 51(1): 110-122 Reference 3 Department of Health (2009) Reference guide to consent for examination or treatment (2nd Edition). London, Department of Health. Reference 4 El-Matary W (2008 (...) ) Percutaneous endoscopic gastrostomy in children. Canadian Journal of Gastroenterology and Hepatology 22(12): 993-998 Reference 5 Erdil A, Saka M, Ates Y, Tuzun A, Bagci S, Uygun A, Yesilova Z, Gulsen M, Karaeren N, Dagalp K (2005) . Journal of Gastroenterology Hepatology 20(7): 1002-1007 Reference 6 Loser C, Aschl G, Hebuterne X, Mathus-Vliegen EMH, Muscaritoli M, Niv Y, Rollins H,Singer P, Skelly RH (2005) ESPEN guidelines on artificial enteral nutrition Percutaneous endoscopic gastrostomy (PEG). Clinical

2014 Publication 1593

140. Cytotoxic and cytostatic medication - safe handling and administration

the most recent evidence based practice. Please use with caution. The purpose of this document is to provide guidance about the control of MRSA at Great Ormond Street Hospital (GOSH). Please note that this is a GOSH clinical guideline and may vary from other external hospital MRSA policies or guidelines. The purpose of this guideline is to provide guidance on the collection of microbiology and virology specimen at Great Ormond Street Hospital (GOSH). Parenteral nutrition (PN) is the administration (...) of nutrition directly into the bloodstream. It is the method of providing nutrition to children who have intestinal failure. Five per cent glucose solution is no longer commercially available. This guideline explains how a solution can be made up on the ward by adding dextrose monohydrate (eg Nutrivit glucose powder) to a 90ml bottle of sterile water. The purpose of this guideline is to provide guidance about intravenous and subcutaneous immunoglobulin infusions at Great Ormond Street Hospital (GOSH

2015 Publication 1593

Guidelines

Guidelines – filter by country